Ramírez-Jirano LJ, Zenteno-Savín T, Gaxiola-Robles R, Ramos-González EJ, Torres-Mendoza BM, Bitzer-Quintero OK

Idioma: Español
Referencias bibliográficas: 31
Paginas: 292-298
Archivo PDF: 247.93 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Tschoeke SK, Oberholzer A, Moldawer LL, Interleukin-18: A novel prognostic cytokine in bacteria-induced sepsis. Crit Care Med. 2006;34:1225-33.

2. Steinman L. Elaborate interactions between the immune system and nervous system. Nat Immunol. 2004;5:575-81.

3. Wrona D. Neural-immune interactions. An integrative view of the directional relationships between the brain and immune system. J Neuroimmunol. 2006;172:38-58.

4. Haddad JJ, Saade NE, Safich-Garabedian B. Cytokines and neuro- immune-endocrine interactions: a role for the hypothalamicpituitary- adrenal revolving axis. J Neuroimmunol. 2002;133:1-19.

5. Schultzberg M, Lindberg C, Aronsson AF. Inflammation in the nervous system- physiological and pathophysiological aspects. Behavior. 2007;92:121-8.

6. Immune Surveillance of the Human Central Nervous System (CNS): Different Migration Pathways of Immune Cells through the Blood-Brain Barrier and Blood-Cerebrospinal Fluid Barrier in Healthy Persons. Cytometry Part. 2006;69:147-51.

7. Czapski GA, Gajkowska B, Strosznajder JB. Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus. Brain Res. 2010;1356:85-94.

8. Semmler A, Hermann S, Mormann F, et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation. 2008;5:38.

9. Sharshar T, Hopkinson NS, Orlikowski D, Annane D. Science review: The brain in sepsis--culprit and victim. Crit Care. 2005;9: 37-44.

10. Taupin P. The hippocampus: neurotransmission and plasticity in the nervous system. 2007, New York: Nova Biomedical Books. p 144.

11. Cavaglia M, Dombrowski SM, Drazba J, Vasanji A, Bokesch PM, Janigro D. Regional variation in brain capillary density and vascular response to ischemia. Brain Res. 2001;910:81-93.

12. Ouyang YB, Voloboueva LA, Xu LJ, Giffard RG. Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J Neurosci. 2007;27:4253-60.

13. Buemi M, Caccamo C, Nostro L, Cavallaro E, Floccari F, Grasso G. Brain and cancer: the protective role of erythropoietin. Med Res Rev. 2005;25:245-59.

14. Buemi M, Cavallaro E, Floccari F, et al. Erythropoietin and the brain: from neurodevelopment to neuroprotection. Clin Sci (Lond). 2002;103:275-82.

15. Hojman P, Taudorf S, Lundby C, Pedersen BK. Erythropoietin augments the cytokine response to acute endotoxin-induced inflammation in humans. Cytokine. 2009;45:154-7.

16. Joyeux-Faure M. Cellular protection by erythropoietin: new therapeutic implications. J Pharmacol Exp Ther. 2007;323:759-62.

17. Wilms H, Schwabedissen B, Sievers J, Lucius R. Erythropoietin does not attenuate cytokine production and inflammation in microglia-implications for the neuroprotective effect of erythropoietin in neurological diseases. J Neuroimmunol. 2009;212: 106-11.

18. Bitzer-Quintero OK, Dávalos-Marín AJ, Ortiz GG, et al. Antioxidant activity of tryptophan in rats under experimental endotoxic shock. Biomed Pharmacother. 2010;64:77-81.

19. Srinivasan V, Pandi-Perumal SR, Spence DW, Kato H, Cardinali DP. Melatonin in septic shock: some recent concepts. J Crit Care. 2010;25:656.e1-6.

20. Srinivasan V, Mohamed M, Kato H. Melatonin in bacterial and viral infections with focus on sepsis: a review. Recent Pat Endocr Metab Immune Drug Discov. 2012;6:30-9.

21. Tao W, Wen F, Zhang H, Liu G. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy. Brain Dev. 2009;31:200-7.

22. Tonges L, Schlachetzki JC, Weishaupt JH, Bhar M. Hematopoietic cytokines-on the verge of conquering neurology. Curr Mol Med. 2007;7:157-70.

23. Feria-Velasco A, Karnovsky MJ. Optimal central nervous system preservation with glutaraldehyde perfusion for ultrastructural study. Arch Invest Med (Mex). 1970;1:201-20.

24. Abramoff MD, Magelhaes PJ, Ram SJ. Image Processing with ImageJ. Biophotonics Int. 2004;11:36-42.

25. Towfighi J, Mauger D. Temporal evolution of neuronal changes in cerebral hypoxia-ischemia in developing rats: a quantitative light microscopic study. Brain Res Dev Brain Res. 1998;109:169-77.

26. Maiese K, Chong ZZ, Shang YCh, Wang S. Erythropoietin: New directions for the nervous system. Int J Mol Sci. 2012;13: 11102-29.

27. Hatshell S, RowlandsT, Hiremath M, Cowin P. Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia. 2003;8:145-58.

28. Byts N, Sirén A-L. Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med. 2009;1:4.

29. Hellewell SC, Yan EB, Alwis DS, Bye N, Morganti-Kossmann MC. Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. J Neuroinflammation. 2013; 10:156.

30. Ponce LL, Navarro JC, Ahmed O, Robertson CS. Erythropoietin neuroprotection with traumatic brain injury. Pathophysiol. 2013; 20:31-8.

31. Sun Y, Calvert JW, Zhang JH. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators, after erythropoietin administration. Stroke. 2005;36:1672-8.